A new report details the case of a patient on the new experimental Alzheimer's drug, lecanemab, who died after experiencing numerous acute intracerebral hemorrhages during treatment with tissue ...

Immediate impact The results of CLEAR III show tPA treatment significantly decreases mortality in one of the worst forms of hemorrhagic stroke. Analyses led by Awad and his team revealed the most ...

Most U.S. hospitals did not give an approved acute stroke drug to any Medicare patients between 2005 and 2007, and a large portion of the general population does not have ready access to a hospital ...

According to the American Stroke Association, stroke is the nation's No. 3 killer. Statistics show that someone in America has a stroke every 53 seconds. That adds up to approximately 600,000 people ...

Using an ambulance that included a computed tomography (CT) scanner, point-of-care laboratory, telemedicine connection and a specialized prehospital stroke team resulted in decreased time to treatment ...

Taking an anticoagulant, or blood-thinning medication, can increase one's risk of—or exacerbate—a brain bleed, also known as a brain hemorrhage, which is the deadliest type of stroke. Now, new ...

Circulating interleukin-18 (IL-18) as a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.